# Postgresome Product Strategy

This document defines the commercial and product strategy for Postgresome as a
premium PostgreSQL diagnosis product.

## Product thesis

Postgresome should become the diagnosis layer for PostgreSQL.

It should not compete primarily on dashboards, generic monitoring, or raw
metric exploration. It should compete on reducing time to understanding and
time to action when a PostgreSQL-backed system degrades.

Core promise:

```text
Tell me what is wrong with Postgres,
why it is happening,
what changed,
what proves it,
and what I should do next.
```

## Category

Postgresome should position itself as:

- PostgreSQL diagnosis assistant
- database doctor for developers
- diagnosis-first Postgres operations product

It should avoid positioning itself as:

- a general observability suite
- a BI-style dashboard
- a generic metrics explorer
- a broad infrastructure monitoring product

## Why this matters

Many teams already have:

- cloud provider charts
- logs
- APM tools
- some PostgreSQL metrics

What they often do not have is a trustworthy diagnosis workflow that connects:

- symptoms
- related database evidence
- likely causes
- recommended next steps

That gap is where Postgresome should win.

## Target customer profile

### Primary ICP

Postgresome is strongest for:

- B2B SaaS teams
- 5 to 50 engineers
- 1 to 20 production PostgreSQL databases
- no full-time DBA
- moderate to high delivery velocity
- real customer impact when performance regresses

### Best-fit environments

- Amazon RDS
- Google Cloud SQL
- Supabase
- Neon
- self-hosted PostgreSQL
- mixed estates across multiple providers

### Primary buyer

- engineering manager
- staff backend engineer
- platform lead
- SRE lead
- CTO at early scale

### Primary user

- backend engineer on incident duty
- platform engineer investigating database slowdowns
- tech lead reviewing database health after deploys

## Trigger moments

Teams are likely to buy when one or more of these become true:

- incidents now take too long to debug
- query regressions recur after deploys
- engineers keep guessing whether the issue is queries, locks, vacuum, cache,
  bloat, or schema design
- PostgreSQL performance problems consume meaningful engineering time
- the company has enough scale to feel database pain but not enough maturity to
  hire or retain deep DBA expertise

## Core differentiators

Postgresome should differentiate through:

1. Diagnosis-first workflow
2. Historical reasoning linked to findings
3. Evidence-backed explanations
4. Cross-provider PostgreSQL support
5. Non-DBA usability for application teams

## Product principles

1. Findings are the product center.
2. Evidence exists to support a finding, not replace it.
3. Historical data exists to explain change over time, not to fill screens.
4. Recommendations must be traceable to evidence.
5. Trust is more important than breadth.
6. Fewer useful findings beat many noisy findings.

## Strategic wedge

The first wedge should be:

```text
Postgres diagnosis for teams that do not want to become DBA experts.
```

That wedge is strong because it:

- aligns with premium willingness to pay
- avoids competing only on commodity charting
- supports both direct connections and managed providers
- can expand naturally into team workflow, alerts, regression analysis, and
  remediation guidance

## Long-term expansion path

Once the diagnosis core is strong, Postgresome can expand into:

- regression alerts
- provider-aware recommendations
- fleet-level health rollups
- collaboration and ownership workflows
- CI and PR risk analysis
- remediation suggestions and verification loops

The order matters: Postgresome should earn trust through diagnosis quality
before trying to automate more of the database workflow.
